HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease.

Abstract
A genetic variation in the 3'-untranslated region of the prothrombin mRNA (20210 G/A) has recently been reported to be associated with elevated plasma prothrombin levels and with an increased incidence of venous thrombosis. We determined the frequency of this mutation, the detection of which was improved by allele-specific amplification of exon 14 and by denaturing gradients (denaturing gradient gel electrophoresis), in cohorts of patients affected by venous thrombosis (n = 132) or by coronary or cerebrovascular diseases (n = 195) and in normal subjects from various populations. An overlapping frequency of the heterozygous genotype (4%) was found in normal subjects from Italy and Cyprus, and no carrier was detected in 40 subjects of Indian or Somali origin. The 20210 GA heterozygous genotype was not increased in frequency in patients with arterial disease. In contrast, the GA genotype was associated (P = .007) with venous thrombosis both in simple heterozygotes (16%) with a family history of thrombosis as well as in double heterozygotes (14%) for other known thrombophilic defects. A synergic interaction between the prothrombin 20210 GA genotype and the factor V Leiden mutation, both potentially affecting the prothrombinase complex, was suggested by the early onset of thrombosis (median age 22 years) in doubly heterozygous patients. The association of the 20210 A allele with higher prothrombin levels was confirmed in the Italian population. However, the prothrombin assay does not allow an efficient preselection of patients for the DNA analysis.
AuthorsP Ferraresi, G Marchetti, C Legnani, E Cavallari, E Castoldi, F Mascoli, D Ardissino, G Palareti, F Bernardi
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 17 Issue 11 Pg. 2418-22 (Nov 1997) ISSN: 1079-5642 [Print] United States
PMID9409210 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • factor V Leiden
  • Factor V
  • Prothrombin
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Alleles
  • Cerebrovascular Disorders (epidemiology, genetics)
  • Cohort Studies
  • Comorbidity
  • Coronary Disease (epidemiology, genetics)
  • Cyprus (ethnology)
  • DNA Mutational Analysis
  • Ethnicity (genetics)
  • Factor V (analysis)
  • Female
  • Gene Frequency
  • Heterozygote
  • Humans
  • India (ethnology)
  • Italy (epidemiology)
  • Male
  • Middle Aged
  • Point Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Prothrombin (genetics)
  • Puerperal Disorders (epidemiology, genetics)
  • Pulmonary Embolism (epidemiology, etiology)
  • Somalia (ethnology)
  • Thrombophilia (epidemiology, genetics)
  • Thrombophlebitis (epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: